Literature DB >> 26855487

Protective Role of Bilirubin Against Increase in hsCRP in Different Stages of Hypothyroidism.

Suparna Roy1, Ushasi Banerjee1, Anindya Dasgupta1.   

Abstract

In conjunction with thyroxine, bilirubin may play an important role for regulation of hsCRP level and a consequent pro-inflammatory condition in hypothyroidism. In present study we evaluated the dependence of hsCRP changes on total bilirubin (BT) and fT4 level in thirty overt (OH) and thirty subclinical hypothyroidism (SH). Serum BT, hsCRP, thyroxine and TSH were measured in both groups and compared with forty control subjects. Serum values of TSH, hsCRP showed raised (P < 0.001 for both) values with lower levels for fT4 and BT (P < 0.001 and 0.03 respectively) in hypothyroid patients compared to the controls. ANOVA showed significant increments in TSH and hsCRP values with decreases in fT4 among the control, SH and OH groups respectively (P < 0.001). BT values showed decrease in OH group only in comparison to controls (P = 0.04). Regression analysis revealed that hsCRP was negatively dependent on fT4 (β = -0.35, P = 0.002) and serum bilirubin (β = -0.40 and P < 0.001 respectively). Univariate general linear model analysis showed this dependence persisted even when carried out distinctly in SH and OH groups separately (P < 0.001). TSH did not show any significant predictive value on the hsCRP level in either of these two tests. From these analyses we suggest that serum hsCRP is closely integrated to a lowered synthesis of bilirubin and fT4 in hypothyroid patients. Furthermore, this causal relationship is not only limited to overt but also extends to the SH.

Entities:  

Keywords:  Overt hypothyroidism; Serum bilirubin; Subclinical hypothyroidism; hsCRP

Year:  2015        PMID: 26855487      PMCID: PMC4731356          DOI: 10.1007/s12291-015-0495-z

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  33 in total

Review 1.  C-reactive protein: a critical update.

Authors:  Mark B Pepys; Gideon M Hirschfield
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

2.  Endothelial dysfunction and low grade chronic inflammation in subclinical hypothyroidism due to autoimmune thyroiditis.

Authors:  Esat Erdem Türemen; Berrin Çetinarslan; Tayfun Şahin; Zeynep Cantürk; İlhan Tarkun
Journal:  Endocr J       Date:  2011-04-14       Impact factor: 2.349

3.  Well-being, health-related quality of life and cardiovascular disease risk profile in women with subclinical thyroid disease - a community-based study.

Authors:  Robin J Bell; Livia Rivera-Woll; Sonia L Davison; Duncan J Topliss; Susan Donath; Susan R Davis
Journal:  Clin Endocrinol (Oxf)       Date:  2007-04       Impact factor: 3.478

4.  Assessment of thyroid disorders and autoimmunity in patients with rheumatic diseases.

Authors:  Akif Acay; Memnune Sena Ulu; Ahmet Ahsen; Selma Eroglu; Ufuk Ozuguz; Seref Yuksel; Gursel Acarturk
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2014       Impact factor: 2.895

5.  C-reactive protein and the risk of incident colorectal cancer.

Authors:  Thomas P Erlinger; Elizabeth A Platz; Nader Rifai; Kathy J Helzlsouer
Journal:  JAMA       Date:  2004-02-04       Impact factor: 56.272

6.  C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men.

Authors:  D E Laaksonen; L Niskanen; K Nyyssönen; K Punnonen; T-P Tuomainen; V-P Valkonen; R Salonen; J T Salonen
Journal:  Diabetologia       Date:  2004-07-28       Impact factor: 10.122

7.  Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins.

Authors:  T W Wu; K P Fung; J Wu; C C Yang; R D Weisel
Journal:  Biochem Pharmacol       Date:  1996-03-22       Impact factor: 5.858

8.  Association of Serum Total Bilirubin with Serum High Sensitivity C-reactive Protein in Middle-aged Men.

Authors:  Kiwoong Yu; Cheolhwan Kim; Eunju Sung; Hocheol Shin; Hyewon Lee
Journal:  Korean J Fam Med       Date:  2011-09-28

9.  Role of surrogate markers of atherosclerosis in clinical and subclinical thyroidism.

Authors:  Mehmet Gunduz; Ercan Gunduz; Fatih Kircelli; Nazan Okur; Mesut Ozkaya
Journal:  Int J Endocrinol       Date:  2012-02-23       Impact factor: 3.257

10.  The relationship of the anti-oxidant bilirubin with free thyroxine is modified by insulin resistance in euthyroid subjects.

Authors:  Petronella E Deetman; Stephan J L Bakker; Arjan J Kwakernaak; Gerjan Navis; Robin P F Dullaart
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.